Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.64 |
| ▸ | CPT2 | P23786 | 2/20 | 0.41 |
| ▸ | CPT1A | P50416 | 2/20 | 0.41 |
| ▸ | CRAT | P43155 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | HRH1 | P35367 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | SLC25A20 | O43772 | 2/20 | 0.30 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL3680487 | 1.00 | SLC22A16 (0.64) | SLC22A16CPT2CPT1ACRATMAPT | |
| Hydrochloric Acid SCHEMBL3675692 | 0.98 | SLC22A16 (0.62) | SLC22A16CPT2CPT1ACRATMAPT | |
| Sulfuric Acid SCHEMBL3672616 | 0.93 | SLC22A16 (0.56) | SLC22A16CPT2CPT1ACRATMAPT | |
| Carnitine SCHEMBL27673497 | 0.84 | SLC22A16 (0.83) | SLC22A16CPT2CPT1ACRATMAPT | |
| Levocarnitine SCHEMBL23249739 | 0.81 | SLC22A16 (0.95) | SLC22A16CPT2CPT1ACRATMAPT | |
| Carnitine SCHEMBL19584826 | 0.81 | SLC22A16 (0.95) | SLC22A16CPT2CPT1ACRATMAPT | |
| Carnitine SCHEMBL31299810 | 0.81 | SLC22A16 (0.77) | SLC22A16CPT2CPT1ACRATMAPT | |
| SCHEMBL3668668 | 0.79 | SLC22A16 (0.42) | SLC22A16CPT2CPT1ACRATMEN1 | |
| SCHEMBL6664365 | 0.79 | SLC22A16 (0.42) | SLC22A16CPT2CPT1ACRATMEN1 | |
| SCHEMBL3669963 | 0.79 | SLC22A16 (0.42) | SLC22A16CPT2CPT1ACRATMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114409570-B | Preparation method of chloridized L-carnitine nitrile | 安徽泰格生物科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-115716788-A | Separation and purification method of L-carnitine | 宁夏坤正生物科技有限公司 | 2023-02-28 | — | — | CN | claimed |
| CN-114409570-A | Preparation method of chlorinated L-carnitine nitrile | 安徽泰格生物科技有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-113603601-A | Production process of L-carnitine | 宁夏坤正生物科技有限公司 | 2021-11-05 | — | — | CN | claimed |
| US-7714166-B2 | Process for producing carnitinamide | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2010-05-11 | — | — | US | claimed |
| US-20090143616-A1 | Process for Producing Carnitinamide | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2009-06-04 | — | — | US | claimed |
| CN-101304965-A | Process for producing carnitinamide | MITSUBISHI GAS CHEMICAL CO (JP) | 2008-11-12 | — | — | CN | claimed |
| EP-1930314-A1 | PROCESS FOR PRODUCING CARNITINAMIDE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2008-06-11 | — | — | EP | claimed |
| EP-0623588-B1 | Improved process for manufacturing L-(-)-carnitine from waste products having opposite configuration | SIGMA TAU IND FARMACEUTI (IT) | 1997-03-12 | — | — | EP | claimed |
| US-5491260-A | ACYLATING CARNITINE NITRILE OR AMIDE, HYDROLYZING UNDER ACID CONDITIONS, LACTONIZING BY TREATING WITH BASE, CONVERTING TO CARNITINE BY TREATING WITH BASE | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1996-02-13 | — | — | US | claimed |
| EP-0508133-B1 | Method of preparation of L-Carnitine from D,L-Carnitine nitrile salts | DEGUSSA (DE) | 1995-02-15 | — | — | EP | claimed |
| EP-0623588-A1 | Improved process for manufacturing L-(-)-carnitine from waste products having opposite configuration | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1994-11-09 | — | — | EP | claimed |
| US-5166426-A | PROCESS FOR PRODUCING L-CARNITINE FROM D,L-CARNITINE NITRILE SALTS | DEGUSSA AG (DE) | 1992-11-24 | — | — | US | claimed |
| EP-0508133-A2 | Method of preparation of L-Carnitine from D,L-Carnitine nitrile salts | DEGUSSA AG (DE) | 1992-10-14 | — | — | EP | claimed |
| EP-0163222-B1 | Process for obtaining aqueous solutions of carnitine amide | BASF Aktiengesellschaft (DE) | 1987-09-09 | — | — | EP | claimed |
| EP-0163223-B1 | PROCESS FOR THE PREPARATION OF CARNITINENITRILE CHLORIDE | BASF Aktiengesellschaft (DE) | 1987-03-04 | — | — | EP | claimed |
| JP-1031751-A | — | — | None | — | — | JP | disclosed |
| JP-1148192-A | — | — | None | — | — | JP | disclosed |
| US-4443627-A | Process for the production of carnitine amide | LONZA LTD. (CH) | 1984-04-17 | — | — | US | disclosed |
| US-4254053-A | Process for manufacturing D camphorate of L carnitinamide and D camphorate of D carnitinamide | Cavazza, Claudio (IT) | 1981-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143616-A1 | Process for Producing Carnitinamide | CRAT, NISCH, NAAA | SLC22A16 904/4885CPT2 5/4885CPT1A 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.